Search This Blog

Wednesday, May 13, 2026

CMS Nationwide Crackdown on Fraud with 6-Month Hospice, Home Health Agency Enroll Moratoria

 Action Builds on Administration’s Whole-of-Government Effort to Crush Fraud and Protect Medicare

In coordination with Vice President JD Vance’s Anti-Fraud Task Force, the Centers for Medicare & Medicaid Services (CMS) is taking decisive action to protect Medicare beneficiaries and taxpayer dollars through implementation of a six-month, nationwide data-driven moratoria on new Medicare enrollment for hospices and home health agencies (HHAs). The moratoria will allow CMS to temporarily halt the influx of new providers into these high-risk categories—a key source of fraudulent activity. Today’s move continues the Trump Administration’s crackdown on fraud, waste, and abuse in the Medicare program by stopping improper billing and preventing bad actors from entering the system.

“We’ve seen systemic and deeply troubling fraud in the hospice and home health space, with bad actors exploiting some of our most vulnerable Medicare patients and stealing money from the American taxpayer,” said CMS Administrator Dr. Mehmet Oz. “Today we’re shutting the door on fraud—preventing new bad actors from entering Medicare while we aggressively identify, investigate, and remove those already exploiting them. This is about protecting patients, restoring integrity, and safeguarding taxpayer dollars.”

During the six-month moratoria, CMS will intensify targeted investigations, deploy advanced data analytics, and accelerate the removal of hospice and HHA providers from the Medicare program that are suspected of committing fraud. This nationwide approach will also eliminate the ability of bad actor operators to evade detection by simply shifting across state lines. In addition, the moratoria will apply to all applications for initial Medicare enrollment and certain changes in majority ownership, which are frequently used to obscure control by bad actors. The moratoria will not impact current enrollments, and existing providers can continue to deliver services to Medicare beneficiaries.

CMS’ announcement today follows our declaration earlier this year of a similar moratorium to prevent fraudulent Medicare billing by certain durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) companies. With three separate moratoria now in place, CMS has taken some of the most significant fraud prevention actions in the agency’s history.

The moratoria are part of CMS’ ongoing efforts to stop fraud before it starts, using data-driven prevention and real-time enforcement as part of a coordinated federal approach. Recent CMS action, undertaken in coordination with Vice President JD Vance’s Anti-Fraud Task Force, has included the suspension of payments to 773 hospices and 23 HHAs suspected of fraud in Los Angeles alone, representing $70 million in suspended funds thus far.

Additional CMS work to crush fraud in the hospice and HHA areas has included:

  • Revoking or deactivating hundreds of hospices and HHAs engaged in improper or fraudulent activity; 
  • Conducting nationwide hospice site visits to verify operations and identify suspicious activity;
  • Heightened oversight of newly enrolled Medicare hospice providers in states with elevated fraud risk, including Arizona, California, Georgia, Ohio, Nevada, and Texas;
  • Launching a new, publicly available hospice scoring system to increase transparency and identify providers with troubling patterns of utilization, quality, or compliance;
  • Implementing enhanced enrollment screening measures for high-risk HHAs, including site verification of reported practice locations and fingerprinting-based background checks; and
  • Expanding a demonstration project that allows pre- and post-claim review of HHA claims in Florida, Illinois, Oklahoma, Ohio, North Carolina, and Texas to stop improper payments before they occur.

Additional information on the Hospice and Home Health Agency moratoria can be found via the Federal Register at: https://www.federalregister.gov/d/2026-09717 (Home Health) and https://www.federalregister.gov/d/2026-09718 (Hospice).

Learn more about CMS’ fraud prevention efforts online at: www.cms.gov/fraud

https://www.cms.gov/newsroom/press-releases/cms-announces-aggressive-nationwide-crackdown-fraud-six-month-hospice-home-health-agency-enrollment

Ukraine, U.S. Draft Defense Deal To Supercharge America's Kamikaze Drone Production

 U.S. and Ukrainian officials have drafted a memorandum that could open a formal channel for Kiev to export battle-tested war technology to the U.S., while also easing the path for U.S. defense firms to form joint ventures with Ukrainian "war unicorns" to mass-produce low-cost, one-way attack drones.

The report comes from CBS News, citing three sources familiar with the matter, who say U.S. State Department officials and Ukraine's Deputy Prime Minister for European and Euro-Atlantic Integration, Olha Stefanishyna, are working on a new defense deal that would capitalize on innovations forged during the four-year grinding war in Ukraine, such as FPVs, AI kill chains, ground robots, drones, and other low-cost technologies that are now proliferating around the world.

Two weeks ago, we pointed out that it was inevitable that Ukrainian drone and counter-drone technologies would soon be exported to the U.S. We tracked U.S.-based Axon's investment deal flow with Ukrainian firms, which suggested this technology was inbound for the U.S. market. Axon's angle is selling to police forces nationwide.

We also noted that the passive acoustics early-warning counter-drone sector is going to heat up (read here), especially in the era of data centers. There are Ukrainian firms with battle-tested counter-UAS systems that the U.S. badly needs.

Also, last month, we joked that Ukrainian President Volodymyr Zelensky went full "Lord of War" and could become the world's top dealer of low-cost drone interceptors.

To our amazement, the U.S.-Iran conflict appears to have accelerated this:

We noted last month:

Ukraine's capital markets have been frozen by war, leaving many of the country's battlefield-proven "war unicorns" starved of traditional funding. However, the Middle East conflict has accelerated a new export pathway, as drone warfare and AI-enabled kill chains reshape how militaries think about defense.

This is exactly what the CBS report said:

Drone collaboration with the U.S., Ukrainian officials told CBS News, would be mutually beneficial, as American financing would help both countries expand their defense production output.

Our view is that a flood of Ukrainian defense firms will transfer battlefield-proven technologies into the U.S. market, tap into deep pools of capital, and leverage underused industrial capacity to scale production of low-cost attack drones and interceptors - this is exactly what the Department of War wants.

This comes as Russia, China, and a growing list of countries race to stockpile drones and interceptors before the next major conflict.

'Iran's Pezeshkian vows war profiteering crackdown'

 Iranian President Masoud Pezeshkian pledged on Wednesday that his government will not tolerate wartime profiteering. Speaking at a meeting on market conditions, he warned against those exploiting the situation to disrupt livelihoods and seek "illegitimate gains through illegal actions." He called for tighter supply chain oversight to prevent stockpiling and uncontrolled price surges, emphasizing that boosting regional trade is key to economic resilience.

In a separate move, Pezeshkian appointed First Vice President Mohammad Reza Aref to lead a new cyberspace headquarters. The president stressed the need for "integrated governance" online to end "conflicting voices" among agencies. The decision comes amid ongoing internet disruptions, now in their 75th day, following restrictions imposed after the US-Israel attacks.

https://breakingthenews.net/Article/Iran's-Pezeshkian-vows-war-profiteering-crackdown/66287084

'Iran: Hormuz control to double our oil revenues'

 Iran's Khatam al-Anbiya Central Headquarters, joint operational command of the Iranian Armed Forces, spokesperson Ebrahim Zolfaghari said on Wednesday that Tehran's oil revenues will double due to the control of the Strait of Hormuz.

"Controlling the Strait of Hormuz will bring us economic revenues twice as high as oil income, while strengthening our foreign policy power. After this war, there will be no retreat," the spokesperson said, as quoted by Iran's ISNA news agency.

Back in March, the Iranian Parliament approved a bill to impose fees on vessels transiting the Strait of Hormuz, with tolls for oil tankers possibly reaching $2 million. However, it is not yet clear if Tehran started charging fees for Hormuz passage.

https://breakingthenews.net/Article/Iran:-Hormuz-control-to-double-our-oil-revenues/66286412

Poland scrambles jets amid drone attacks on Ukraine

 The Polish military said on Wednesday that it scrambled fighter jets and helicopters following a "massive" Russian attack on Ukraine, including a large number of drones. The Operational Command of the Polish Armed Forces said it also placed ground-based air defense and radar reconnaissance systems on heightened alert.

The authorities stressed that the action is "preventative in nature" and aimed at securing Polish airspace, particularly close to areas under Russian strikes. The Operational Command added that it is monitoring the situation and that the military remains ready for an immediate response.

https://breakingthenews.net/Article/Poland-scrambles-jets-amid-drone-attacks-on-Ukraine/66286361

Readout for AZ's hypoparathyroidism drug raises questions

 A drug at the heart of AstraZeneca's takeover of Amolyt has hit the mark in a phase 3 trial, but could be undermined by an efficacy result that doesn’t seem to match up to its main rival.

The CALYPSO trial of eneboparatide hit its primary endpoint by showing that the drug was more effective than placebo at normalising serum calcium levels in people living with hypoparathyroidism, a rare condition caused by a deficiency of parathyroid hormone (PTH) that leads to imbalances in calcium and phosphorus levels in the blood, in turn leading to tissue and organ damage.

Eneboparatide, a PTH 1 receptor agonist, helped 31.1% of patients bring their serum calcium levels into the normal range and come off calcium and vitamin D supplements at 24 weeks, which was significantly better than the 5.9% of patients who achieved that objective with placebo.

The issue for AZ is that Ascendis Pharma's already-marketed Yorvipath (palopegteriparatide) seemed to perform much better against a similar endpoint in the pivotal PaTHway trial, with normalisation of serum calcium levels seen in 79% of patients treated with the drug versus 5% of the placebo group, after 26 weeks.

AZ teased the results of CALYPSO a few months ago, without going into details, and waited until the European Congress of Endocrinology (ECE) this week to reveal the data, including a 52-week follow-up period that showed the benefits of treatment were maintained.

Immunogenicity at fault?

Trying to compare two studies with different protocols and patient populations can always be prone to misinterpretation, and AZ emphasised that CALYPSO is the largest phase 3 trial ever conducted in adult hypoparathyroidism and showed "meaningful and sustained benefits in calcium regulation, symptom burden, physical function and bone health" that were sustained for a year.

That said, the data reveal that eneboparatide caused immunogenic reactions in "the majority of patients," according to AZ, which added that this had resulted in "reduced treatment effects in some patients" that could be offset by giving supplements and raising the dose of the drug.

Immunogenicity leads to the creation of patient antibodies against the drug itself, reducing its ability to exert its pharmacological effects.

Gianluca Pirozzi, head of AZ's Alexion rare disease subsidiary, said that the results support "eneboparatide’s potential to address the broad burden of this complex rare disease and help close persistent gaps in care, given the limited treatment options available."

AZ also pointed to a beneficial impact of eneboparatide on normalising urinary calcium in patients with elevated levels at baseline, with 56.6% of patients seeing levels return to normal ranges at week 24 versus 20% of those in the control group.

That is an important result, as supplements can increase the risk of excess calcium in the urine, and in turn lead to progressive kidney dysfunction and failure from calcium deposition and kidney stones.

There has been no word from AZ on plans to file for approval of eneboparatide, which was the focus of the purchase of French pharma Amolyt two years ago for $800 million upfront and $250 million in potential milestones.

Yorvipath could also face competition from MBX Bio's canvuparatide (formerly MBX 2109), which is due to start a phase 3 trial later this year after hitting the mark in a phase 3 trial. Canvuparatide can be dosed subcutaneously once a week, while both Yorvipath and eneboparatide require a daily injection.

https://pharmaphorum.com/news/readout-azs-hypoparathyroidism-drug-raises-questions

Lowe’s, Home Depot could start spying on you using license plate readers in effort to boost safety

 Lowe’s and Home Depot are ramping up surveillance in store parking lots in states including California, Texas and Connecticut AI-powered license plate readers to combat theft and keep customers safe — but privacy advocates warn the devices could track shoppers’ movements.

The systems can create searchable records showing where vehicles travel, when they arrive and how often they visit certain locations — prompting worries that the technology can amass data about consumer behavior that can be accessible to law enforcement, hackers, private investigators or even misused internally.

Home Depot was named in a class action lawsuit filed last week in California federal court alleging that the department chain was running a covert surveillance system using LPR technology and then feeding that information to a database accessed by law enforcement.

An automated license plate reader camera is seen above. Major retailers have ramped up usage of AI-powered surveillance tools aimed at combating organized retail theft.Christopher Sadowski

Both home-improvement chains have quietly rolled out the systems at some locations across the country, including stores in Connecticut, where NBC Connecticut recently spotted a camera mounted near the entrance to a Lowe’s in Newington, Conn.

Public records first reported by 404 Media showed that a Texas sheriff’s office had searchable access to data from hundreds of license plate reader cameras tied to Lowe’s and Home Depot stores through surveillance firm Flock Safety.

The systems use cameras to capture images of vehicles and license plates along with the time, date and location, according to the companies’ privacy policies.

Robert McWhirter, a constitutional historian and criminal defense lawyer, told The Post the use of surveillance cameras on private property is “probably legal” — though he said the constitutional issues become more complicated once companies share data with law enforcement.

“The key issue is the relationship with law enforcement and what these companies do with the data in their relationship with law enforcement,” McWhirter said.

Lowe’s and Home Depot are increasingly deploying license plate reader technology in parking lots as privacy advocates raise concerns over data sharing with law enforcement.Christopher Sadowski

McWhirter said major retailers already rely heavily on surveillance and artificial intelligence to track suspected shoplifters over time before involving police.

“If they have somebody on camera enough times, they will then call law enforcement and bring them in,” he said.

He added that companies “have the right to do whatever they want to do on their private property,” though he noted legal fights could emerge if the systems are used in discriminatory ways or evolve into broader forms of invasive surveillance.

The growing use of automated license plate reader systems — known as ALPRs — by private retailers comes as stores across the country grapple with organized retail theft rings and repeat shoplifting crews.

Police in Connecticut recently busted a Home Depot theft ring that allegedly operated across nine states, according to NBC Connecticut.

Retailers increasingly view license plate readers as a way to identify vehicles tied to repeat thefts, track suspects entering and leaving parking lots and assist police investigations after crimes occur.

But privacy experts warn that the technology can also create massive databases of innocent shoppers’ movements with fewer safeguards than systems operated by police.

Connecticut lawmakers recently approved legislation imposing new regulations on license plate reader systems, including limits on how long collected data can be stored.

Home Depot was hit with a proposed class action lawsuit in California alleging the company operated a covert surveillance network using LPR technology.David Buchan for Ca Post

Lowe’s says on its website that the technology is being used “to help ensure security, prevent theft and fraud, assist with parking enforcement, and to help maintain your safety and the safety of individuals and our properties.”

The company says access to the data is limited to trained asset protection employees, information security staff and select contractors who maintain the systems.

Lowe’s also says it can disclose the information to law enforcement when responding to “a request from state or local law enforcement,” legal process, crimes committed on store property or “potential criminal activity.”

The retailer says it retains the data for up to 90 days in most cases unless it is needed for an active investigation.

Home Depot confirmed to The Post that it also uses license plate reader technology in parking areas at some stores.

“We’ve had parking area security cameras in place at our stores for many years, as many retailers do,” a Home Depot spokesperson said in a statement.

“These cameras are used solely as a security measure to prevent theft and protect the safety of our customers and associates in our stores.”

The company added: “We do not grant access to our license plate readers to federal law enforcement.”

Home Depot’s online policy similarly states that the company does not sell or share collected license plate information with third parties.

https://nypost.com/2026/05/12/business/lowes-home-depot-could-start-spying-on-you-using-license-plate-readers/